Sandoz
FDA Approves Pyzchiva Biosimilar to Stelara
Pyzchiva was approved for all indications of its reference biologic; the FDA provisionally determined that ...
JULY 16, 2024
New Noninferiority Data for Biosimilar Infliximab
Biosimilar infliximab is not inferior to the originator product, Remicade in treating rheumatoid arthritis and ...
OCTOBER 20, 2016
FDA Approves Erelzi, a Biosimilar to Enbrel
Administered by injection, Erelzi received approval for all the indications of the reference product.
AUGUST 31, 2016
Load more